The UNC Eshelman School of Pharmacy is a key member of the robust research arm of the University of North Carolina at Chapel Hill.

Our faculty are leaders and innovators in their areas of research, and the School’s proximity to the Research Triangle Park and other research campuses spurs collaboration and partnerships in academia and with industry. Research at the School has spawned a number of spin-off companies, and in 2009, the School led the University with twenty-six invention disclosures and four patents received.

If you are looking for opportunities for research collaboration, please visit the Global Engagement section of our website, or explore our Eshelman Institute for Innovation’s resources for entrepreneurial development.

A Unique Perspective

The UNC Eshelman School of Pharmacy provides a unique perspective among peer institutions in our approach to research. The School conducts a wide range of advanced research that aligns with five phases of the drug discovery, development and delivery cycle.

Each phase is represented by a division within the School. Faculty and graduate students alike are encouraged to work with their peers within the School and the University to further realize research goals in discovery, preclinical and clinical development of therapeutic agents, optimum delivery of drug therapy, evaluation of health and therapeutic outcomes of novel drug therapies and technologies, as well as regulatory policies.

Recent Research News

Cao Receives R35 Outstanding Investigator Grant

November 16, 2017

Yanguang “Carter” Cao, Ph.D., has received a R35 Outstanding Investigator Grant worth $1.85 million over five years from the National Institute of General Medical Sciences to create a platform to optimize antibody-based therapy. “Therapeutic antibodies have achieved great success in … Continued

Jeffrey Weidner, Ph.D., of QualSci Consulting discusses robust and reproducible assays at a assay guidance workshop for high-throughput screening and lead discovery hosted by UNC Catalyst.

UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop

October 25, 2017

UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop The UNC Catalyst for Rare Diseases, together with Promega, sponsored an NIH/NCATS assay guidance workshop for high-throughput screening and lead discovery on Monday, October 23. Forty-nine scientists from academia and the pharmaceutical and … Continued


Read More